Patent · US Active

Fused ring compounds

US11236068B2 · kind B2 · utility

3Cited by

12References

40Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Sushant Malhotra · South San Francisco, US
Jianfeng Xin · Beijing, CN
Steven Do · San Jose, US
Jack Terrett · South San Francisco, US

Key dates

Filing date	Nov 8, 2019
Grant date	Feb 1, 2022
Priority date	—
Expiry date	Feb 28, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention pertains to fused ring compounds of Formula (I), as further detailed herein, which are used for the inhibition of Ras proteins, as well as compositions comprising these compounds and methods of treatment by their administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.